Coeffic, David
28  results:
Search for persons X
?
7

Adjuvant docetaxel/cyclophosphamide in breast cancer patien..:

Freyer, Gilles ; Campone, Mario ; Peron, Julien...
Critical Reviews in Oncology/Hematology.  80 (2011)  3 - p. 466-473 , 2011
 
?
9

Prospective Phase II Trial of Irinotecan, 5-Fluorouracil, a..:

Gil-Delgado, Maria Angeles ; Guinet, François ; Castaing, Denis...
American Journal of Clinical Oncology: Cancer Clinical Trials.  24 (2001)  1 - p. 101-105 , 2001
 
?
10

Identification of Neoadjuvant Chemotherapy Response in Musc..:

Mazza, Camille ; Gaydou, Vincent ; Eymard, Jean-Christophe...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14010021.  , 2022
 
?
11

Identification of Neoadjuvant Chemotherapy Response in Musc..:

Mazza, Camille ; Gaydou, Vincent ; Eymard, Jean-Christophe...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14010021.  , 2022
 
?
12

Identification of Neoadjuvant Chemotherapy Response in Musc..:

Mazza, Camille ; Gaydou, Vincent ; Eymard, Jean-Christophe...
info:eu-repo/semantics/altIdentifier/doi/10.3390/cancers14010021.  , 2022
 
?
14

Long-term outcomes in patients with PET-predicted poor-resp..:

Coudert, Benoit ; Pierga, Jean-Yves ; Mouret-Reynier, Marie-Ange...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2020.100566.  , 2020
 
?
15

Long-term outcomes in patients with PET-predicted poor-resp..:

Coudert, Benoit ; Pierga, Jean-Yves ; Mouret-Reynier, Marie-Ange...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.eclinm.2020.100566.  , 2020
 
1-15